,Mexico: COFEPRIS Publishes Self-Verification Guide for Inspection and Traceability of Health Supplies – Drugs
COFEPRIS issues a self-verification guide to support compliance with sanitary inspection and traceability requirements for medicinal and herbal products, providing operational criteria to strengthen internal controls and regulatory readiness.
COFEPRIS | Pharmaceuticals | Regulatory AffairsBrazil: ANVISA approves new regulatory framework for herbal medicines
ANVISA approved a new regulatory framework simplifying registration and expanding the use of biodiversity in herbal medicines in Brazil.
ANVISA | Pharmaceuticals | Regulatory AffairsMexico: COFEPRIS Publishes Catalogue of Criteria and Requirements for Submitting Drug Samples for Analysis
COFEPRIS issued a guidance document detailing the criteria, documentation, and analytical requirements for submitting pharmaceutical, biological, vaccine and API samples for laboratory analysis at CCAYAC-accredited facilities.
COFEPRIS | Pharmaceuticals | Regulatory AffairsColombia: INVIMA Activates New Functionality for CVL Generation with Observations in InvimÁgil
INVIMA activates a new InvimÁgil functionality enabling the issuance of Certificates of Free Sale with observations, enhancing digital regulatory operations and certificate management in Colombia.
INVIMA | Pharmaceuticals | Regulatory AffairsMexico: COFEPRIS Recognizes 2025 Advances of the Permanent Commission of the Mexican Pharmacopoeia
COFEPRIS acknowledges the 2025 advances of the Permanent Commission of the Mexican Pharmacopoeia (FEUM), highlighting continued progress in strengthening official quality standards for medicinal products in Mexico.
COFEPRIS | Pharmaceuticals | Regulatory Affairs
Consult
